Class Action News

Class Action Legal News articles include legal news and lawsuit information about lawsuits filed, settlements reached and verdicts rendered in class action cases dealing with personal injury, defective products, bad drugs and other consumer law related news issues. Many of these articles include interviews from top legal professionals with guidance on legal recourse options from losses resulting from bad drugs, medical malpractice, investment fraud, personal injury, defective products and negligent employers.

Blocked Arteries and Heart Attack While Taking Vytorin
May 1, 2008
Boise, ID: Stephen, a 57-year old police officer, is the picture of health. He cycles regularly, works out regularly, has never smoked, and doesn't drink. About two years ago he went to his doctor for a routine physical, and his cholesterol levels were found to be very high. So his doctor put him Vytorin.
Emergency Triple Bypass Surgery 18 Months After Starting Vytorin
April 30, 2008
Chesterfield: VA A year and half after being on Vytorin, Richard had to undergo emergency triple bypass surgery. His doctor had put him on Vytorin in July 2005, around the time the new cholesterol drug became available. But for eight years prior to that Richard had taken Zocor (simvistatin), one of the two drugs actually contained in the Vytorin pill.
A Life in Limbo
April 19, 2008
Tiffin, OH: Shelva's husband, Raymond, had to go to hospital recently to have his stent replaced. Raymond has taken Vytorin for two years, and began taking the block-buster anti-cholesterol drug just before he had is original stent put in. According to the claims of the makers of Vytorin, Raymond's cholesterol should have been reduced, so much so in fact that he wouldn't need a new stent in such short order, if at all. But that's not what happened. Vytorin didn't reduce either Raymond's cholesterol levels, or those of his wife, who was also taking the drug.
Vytorin and Zetia May Not Work: Cardiologists
March 31, 2008
Chicago, IL The message could not have been clearer. At a major cardiology conference Sunday in Chicago, a gathering of 5,000 of the country's leading cardiologists were told unequivocally that cholesterol drugs Vytorin and Zetia should only be used as a therapy of last resort, given the now-widely-held view that the two drugs may not work.
Merck/Schering Tries to Wine and Dine Vytorin Back to Health
March 24, 2008
Kenilworth, NJ Since the results of the ENHANCE clinical tests for Merck/Schering-Plough's Vytorin combination anti-cholesterol drug were released in mid-January, sales of the drug have plunged as much as 17 percent. That's because the ENHANCE results showed that the $3-a-pill Vytorin, which combines Merck's Zetia with generic simvastatin, did no better than inexpensive simvastatin alone at lowering users' arterial plaque, and thus their risk for stroke or heart attack.
Zetia/Vytorin: "He was a good man and his life was cut short."
March 21, 2008
Parachute, CO: Melissa Cruz's father was diagnosed with diabetes in 1996. That's why today she continues to wonder why in 2002 his doctor prescribed him Merck/Schering-Plough's Zocor, then added Zetia about a year later, and again in 2007—the same combination of anti-cholesterol drugs used in the companies' Vytorin.
Vytorin: "My Heart Attack could have been Prevented"
March 19, 2008
St. George, UT About two years ago, Deloy's doctor prescribed Vytorin to lower his cholesterol. "My doctor was taking it as well so that was good enough for me," says Deloy. "Then I saw ads on TV about how great it was and that reassured me even more—it takes care of what your mum gave you and what your wife gives you." But Vytorin didn't give. In fact, it took.
Vytorin: "No one could tell me why I had a heart attack."
March 18, 2008
Dalton, GA Until a year ago, Larry Matthews had a normal life in this area near the Georgia-Tennessee border. He was physically active at home and at work, and like many men of a certain age, was keeping an eye on his cholesterol and blood pressure. That was before Vytorin, the combination Zetia/Zocor (simvastatin) anti-cholesterol drug from Merck/Schering-Plough, changed things for the worse.
Vytorin: Yet Another Consumer Complaint
March 13, 2008
Lafayette, LA Imagine taking a drug that costs about three times more than similar medications, doesn't work and even does more harm than good. Colin G. doesn't have to imagine: he took Vytorin and is suffering the consequences. He wonders how drug makers could fraudulently market a drug and put people's lives at risk.
Woman Suspicious of Vytorin's Side Effects
March 4, 2008
Lake Havasu City, AZ Liz has always harbored suspicions about medications she could not substantiate and sitting at the top of her list is Vytorin, the cholesterol-lowering drug she has taken for five years.
Vytorin - A Costly Risk
March 3, 2008
Clarksville, IN The cost of Vytorin, a cholesterol-lowering drug, is taking such a chunk out of Jack's monthly budget he is reduced to begging for samples. But beyond the financial strain, he is also beginning to worry about its long term effect on his health.
Vytorin: High Priced Dud Accused of False Advertising
March 3, 2008
Jacksonville, FL This is the story of a drug company, like most other drug companies, that appears to put the profits ahead of the people. At least, that's the accusation coming from a dear, old 72-year-old grandmother who is serving as the lead plaintiff for a potential class-action lawsuit against the makers of Vytorin.
Vytorin: Good for Absolutely Nothing
February 29, 2008
New York, NY "My doctor had me on Zetia and Zocor then I switched to Vytorin when it came on the market," says Jeffrey Aaronson. "Every month I spent $200 on this drug and all I got were nasty side effects." He also got two more heart attacks. Aaronson believes that he was duped into taking Vytorin because of the company's fraudulent marketing, even after it knew that Vytorin (and Zocor) had no effect in preventing plaque buildup in the arteries.
Patients Duped by Fraudulent Marketing of Vytorin
February 20, 2008
Atlanta, GA "Vytorin should be accused of fraudulent marketing just on the price alone," says Garry Jones. "And it was marketed as something that it did not do and because of this, I suffered a heart attack."
Vytorin doing more Harm than Good
February 17, 2008
Baton Rouge, LA The last thing Denise J. thought about was heart disease when her doctor prescribed Vytorin to lower her cholesterol count. But matters of the heart are as serious as a heart attack. "I was prescribed Vytorin over a year ago and was feeling fine, but now I'm like an old person and I'm only 49 years old," she says. A recent EKG has her worried.
Vytorin: Not even doing half its Claim
February 7, 2008
Pinson, AL "I started taking Vytorin two years ago with the assumption that it would treat two things: good and bad cholesterol," says John Harris. "Now I am finding out about Vytorin's side effects and it doesn't look good."

Request Legal Help

Please complete this form to request a review of your complaint by an attorney.

First name Last name Email address Phone number Zip Defendant (who are you accusing?) Describe your complaint: Category that best suits your complaint Receive our weekly newsletter from our sister publication LawyersandSettlements with the latest lawsuit news and legal information.

By submitting this form I agree to the Terms of Service.

There is absolutely no cost to you to submit this form. Doing so places you under no obligations and does not establish an attorney-client relationship.

Visit other Online Legal Media Websites: